Grapiprant
Specifications
415903-37-6CAS Number
112-524-8EC Number
1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylureaIUPAC Name
C26H29N5O3SChemical Formula
491.6 g/molMolecular Weight
Grapiprant; 415903-37-6; CJ-023423; CJ 023423; CJ-023,423; AAT-007; MR-10A7; CJ-023; MR10A7; RQ-00000007; J9F5ZPH7NB; DTXSID60194419; 1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea; Benzenesulfonamide, N-(((2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)amino)carbonyl)-4-methyl-; 1-(2-(4-(2-ethyl-4,6-dimethylimidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-3-(4-methylphenyl)sulfonylurea; grapiprantum; Galliprant; 3-(2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-1-(4-methylbenzenesulfonyl)urea; 3-[2-(4-{2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl}phenyl)ethyl]-1-(4-methylbenzenesulfonyl)urea; RefChem:57297; DTXCID20116910; RQ-07; CJ023,423; CJ 023,423; N-(((2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl) phenyl)ethyl)amino)carbonyl)-4-methylbenzenesulfonamide; N-((2,4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenylethylamino)carbonyl)-4-methyl-benzenesulfonamide; N-((4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethyl)carbamoyl)-4-methylbenzenesulfonamide; RQ-7; CJ-023423 Hydrochloride Salt, Hydrate; N-[[[2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methylbenzenesulfonamide; CJ-023423;RQ-00000007;AAT-007; Grapiprant [USAN:INN]; UNII-J9F5ZPH7NB; Grapiprant (CJ-023423); Grapiprant?; C26H29N5O3S; N-(((2-(4-(2-ETHYL-4,6-DIMETHYL-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)PHENYL)ETHYL)AMINO)CARBONYL)-4-METHYLBENZENESULFONAMIDE; N-[([2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino)carbonyl]-4-methylbenzenesulfonamide; MFCD16628076; A1ECR; GRAPIPRANT [MI]; GRAPIPRANT [INN]; Grapiprant (USAN/INN); GRAPIPRANT [USAN]; GRAPIPRANT [WHO-DD]; SCHEMBL120428; GTPL5858; orb1296072; GRAPIPRANT [GREEN BOOK]; CHEMBL3039498; Grapiprant (CJ-023,423); SCHEMBL29496330; HZVLFTCYCLXTGV-UHFFFAOYSA-N; EX-A2544; QRA90337; BDBM50107283; s6694; TQ0292; AKOS030526811; CS-5392; DB12836; EBC-615697; SB18902; NCGC00476033-02; AC-36123; AS-77380; DA-53699; HY-16781; NS00072230; D10638; D83673; F841053; G681019; BRD-K62050508-001-01-0; Q27077852; CJ-023423; RQ-00000007; AAT-007; Grapiprant; RQ-00000007; AAT-007; CJ-023423; 1-[2-[4-(2-ethyl-4,6-dimethyl-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea; 2-ETHYL-4,6-DIMETHYL-1-(4-(2-(((((4-METHYLPHENYL)SULFONYL)AMINO)CARBONYL)AMINO)ETHYL)PHENYL)-1H-IMIDAZO(4,5-C)PYRIDINE; N-(((2-(4-(2-ETHYL-4,6-DIMETHYL-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)PHENYL)ETHYL)AMINO)CARBONYL)-4-METHYL-BENZENESULFONAMIDE; N-({2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl}carbamoyl)-4-methylbenzene-1-sulfonamide; N-(4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethylcarbamoyl)-4-methylbenzenesulfonamideSynonyms
